NP / PA
Dougherty, Anne
Dougherty, Anne was paid $73K by Medicaid between Jul 2021 and Dec 2024, across 7 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 77% of everything it billed.
33Billing provider infoDOUGHERTY, ANNE
SUGAR GROVE, IL 60554
SUGAR GROVE, IL 60554
33aNPI1558384487assigned 07/25/2006
33bProvider typeNurse Practitioner
28Total paid$73K
24GClaims1,596
24DCodes billed7
24AFirst – last monthJul 2021 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Illinois
Rank by total paid#428 of 1,687
Median peer was paid$22K
This provider vs. median3.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 266 | $10K | |
| 2022 | 493 | $22K | |
| 2023 | 639 | $29K | |
| 2024incomplete | 198 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 77% | 1,280 | 1,221 | $56K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6.8% | 70 | 66 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.9% | 84 | 82 | $4K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.3% | 45 | 45 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 33 | 31 | $1K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.7% | 25 | 25 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 59 | 58 | $904.95 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.